Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
305.00    0.50 (0.16%)
Bid:
304.50
Ask:
305.00
Spread: 0.50 (0.164%)
Market Cap: £180.06m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Trading Update

22 Jan 2021 07:00

RNS Number : 5318M
Treatt PLC
22 January 2021
 

22 January 2021

TREATT PLC

("Treatt" or "the Group")

Trading update

Strong trading - profits expected to materially exceed market consensus

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, today updates on trading since the start of its financial year ending 30 September 2021 ("FY21").

Highlights

· Strong operating performance across multiple categories and customers, with new organic revenue growth and enhanced margins from improving product mix.

· Profits for the first four months of the current financial year are expected to be ahead of Board's previous expectations for the period.

· Continued partnering with customers to develop exciting products in the fast-evolving beverages market is driving potential for further revenue and margin growth.

· Headwinds from COVID-19, the geopolitical landscape and commodity/currency risks remain.

· Overall, the Board is cautiously optimistic that the current strong momentum will result in profit before tax and exceptional items for FY21 materially exceeding the current market consensus* of £15.1m.

Trading performance

As reported in our FY20 results announcement on 24 November 2020, the Group had a strong start to the new financial year, and this has continued with the trading performance in the year to date being significantly better than expected.

The Group is performing particularly well in its citrus, health & wellness, fruit & vegetables and tea categories. Some material new business wins have been achieved including in the global alcoholic seltzer category which is continuing to grow strongly. Treatt is well positioned as a supplier of natural extracts including its sugar reduction solutions; the Group's technical expertise enables it to add significant value to customers across a growing range of applications resulting in margin expansion as well as revenue growth.

Whilst some parts of our product portfolio continue to be impacted from subdued on-trade demand due to the closure of venues in many parts of the World, this has been more than offset by increased demand from off-trade channels.

The Board considers that the strong trading momentum shown in these first few months of the current financial year will continue into H2 but is mindful that the Group faces the same uncertainties as our customers regarding the ongoing COVID-19 global pandemic, potential further lockdowns in our key markets and the volatile geopolitical landscape, with potential impacts on demand, FX rates and commodity prices. Nevertheless, the better than expected performance for the first four months of the year and the level of the order book leads the Board to be cautiously optimistic about continued growth in revenues, margins and profits for the rest of FY21, with profit before tax and exceptional items for FY21 expected to materially exceed current consensus* of £15.1m.

Daemmon Reeve, CEO, commented:

"We're encouraged by our strong trading momentum continuing into the current financial year. Performance has been positive across a number of our key categories, with particular growth in our solutions for the expanding alcoholic seltzer market, utilising our expertise in natural extracts.

"Whilst mindful of the global backdrop, we are confident that we can make further progress this year, to grow organic revenue across an increasingly global and diversified customer base who benefit from our technical expertise and value-add approach."

 

* Treatt compiled consensus of analyst forecasts for FY21 of profit before tax and exceptional items.

 

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Chief Financial Officer

 

Broker

Investec Bank Plc +44 (0)20 7597 5970

Patrick Robb

David Anderson

Alex Wright

 

Financial PR

MHP Communications +44 (0) 20 3128 8789

Tim Rowntree

Simon Hockridge

Catherine Chapman

 

About the Group

Treatt is a global, independent manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 300 staff in Europe, North America and Asia and has manufacturing facilities in the UK and US. Its international footprint enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

 

For further information about the Group, visit www.treatt.com.

 

Information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLALLILFIL
Date   Source Headline
1st May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
1st May 202611:43 amRNSForm 8.3 Treatt plc
1st May 202611:03 amRNS20260430_TREATT PLC_8.5 EPT RI_UK_MLI
1st May 202610:03 amRNSForm 8.3 TREATT PLC
1st May 20269:23 amGNWForm 8.5 (EPT/RI)-Treatt Plc
1st May 20269:23 amBUSForm 8.5 (EPT/RI)-Treatt Plc
30th Apr 20263:27 pmRNSForm 8.3 - TREATT PLC
30th Apr 20263:20 pmRNSForm 8.3 - Treatt plc
30th Apr 20262:28 pmRNSForm 8.3 - Treatt PLC
30th Apr 20261:13 pmRNSForm 8.3 TREATT PLC
30th Apr 202612:45 pmRNSForm 8.3 - Treatt plc
30th Apr 202612:23 pmRNSForm 8.3 Treatt plc AXA IM UK
30th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
30th Apr 202611:47 amRNSForm 8.3 Treatt Plc
30th Apr 202611:42 amRNSForm 8.3 - Treatt Plc
30th Apr 202610:53 amRNS20260429_TREATT PLC_8.5 EPT RI_UK_MLI
30th Apr 202610:51 amGNWForm 8.5 (EPT/RI)- Treatt Plc
30th Apr 202610:51 amBUSForm 8.5 (EPT/RI)- Treatt Plc
30th Apr 20269:46 amGNWForm 8.3 - [TREATT PLC - OPENING DISCLOSURE - 29 04 2026] - (CGAM)
30th Apr 20269:46 amBUSForm 8.3 - [TREATT PLC - OPENING DISCLOSURE - 29 04 2026] - (CGAM)
29th Apr 20264:43 pmRNSUpdate on Letters of Intent
29th Apr 202611:40 amRNSForm 8.3 - Treatt plc
29th Apr 20267:45 amRNSDisclosure Table
29th Apr 20267:01 amRNSHalf Year Results
29th Apr 20267:00 amRNSRecommended cash acquisition of Treatt plc
7th Apr 20267:00 amRNSDirectorate and Board Committee Changes
26th Mar 20263:52 pmRNSResult of AGM
26th Mar 20267:00 amRNSAGM Trading Update
4th Mar 20264:00 pmRNSHolding(s) in Company
19th Feb 20262:54 pmRNSVoting Rights and Capital
12th Feb 20267:00 amRNSUpdate on CFO Recruitment and Board Committees
30th Jan 20264:13 pmRNSAnnual Report and Notice of Annual General Meeting
26th Jan 20264:02 pmRNSHolding(s) in Company
20th Jan 20267:01 amRNSRelationship Agreement and Board Appointment
20th Jan 20267:00 amRNSFull Year Results
12th Jan 20264:25 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNSBoard and Management Appointments & Results Notice
3rd Dec 20257:00 amRNSDirectorate change
1st Dec 202510:24 amRNSBlock Listing Six Monthly Return
1st Dec 202510:21 amRNSBlock Listing Six Monthly Return
25th Nov 20257:00 amRNSDirectorate change
21st Nov 20257:00 amRNSDirectorate change
4th Nov 20251:15 pmRNSForm 8.3 - Treatt Plc
4th Nov 20251:09 pmRNSForm 8.3 TREATT PLC
4th Nov 202512:00 pmRNSForm 8.5 (EPT/RI) Treatt Plc
4th Nov 20259:18 amGNWForm 8.5 (EPT/RI)-Treatt plc
3rd Nov 20253:41 pmRNSResults of Court Meeting and General Meeting
3rd Nov 20253:20 pmRNSForm 8.3 - Treatt Plc
3rd Nov 20253:17 pmRNSForm 8.3 - TREATT PLC
3rd Nov 20252:36 pmRNSForm 8.3 TREATT PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.